Stock comparison
Drugs Made In America Acquisition II Corp. Ordinary Shares
Palomar Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market cap
$528.3M
Sector
Financials
PLMR
Palomar Holdings
Market cap
$3.02B
Sector
Financials
Overall winner
Palomar Holdings PLMR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | DMII | PLMR | Winner |
|---|---|---|---|
| Warren Buffett | 16F | 73B | PLMR |
| Benjamin Graham | 5F | 63C | PLMR |
| Philip Fisher | 15F | 74B | PLMR |
| Peter Lynch | 10F | 60C | PLMR |
| Joel Greenblatt | 33F | 31F | DMII |
| Charlie Munger | 8F | 56C | PLMR |
| Terry Smith | 13F | 57C | PLMR |
Side-by-side metrics
| Metric | DMII | PLMR |
|---|---|---|
| Market cap | $528.3M | $3.02B |
| P/E (TTM) | 1.2x | 15.5x |
| EV/EBIT | - | 13.0x |
| ROIC (TTM) | -0.26% | 11.53% |
| Gross margin | 0.0% | 60.65% |
| Net margin | 0.0% | 20.15% |
| Revenue CAGR 5y | - | 37.12% |
| EPS CAGR 5y | - | 42.39% |
| Debt / Equity | - | 0.3x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
DMII leads on
- EV/EBIT-vs 13.0x+130%
- Debt / Equity-vs 0.3x+100%
- P/E (TTM)1.2xvs 15.5x+92%
PLMR leads on
- ROIC (TTM)11.53%vs -0.26%+102%
- Gross margin60.65%vs 0.0%+100%
- Net margin20.15%vs 0.0%+100%
- Market cap$3.02Bvs $528.3M+82%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.